Latest Capecitabine Stories
BUFFALO, N.Y., Oct.
PITTSBURGH, Aug. 11, 2014 /PRNewswire/ -- Mylan Inc.
Tokyo, July 3, 2014 - (JCN Newswire) - Eisai Co., Ltd.
Indication of Anticancer Agent Halaven for Use in Earlier-Line Treatment of Advanced Breast Cancer Tokyo, May 27, 2014 - (JCN Newswire)
The Majority of Surveyed Oncologists Have Already Prescribed Kadcyla, Just Nine Months Post-Launch, According to Findings from Decision Resources Group BURLINGTON, Mass., March 18, 2014 /PRNewswire/
SEATTLE AND BOULDER, CO, Feb. 3, 2014 /PRNewswire/ - Oncothyreon Inc. (NASDAQ: ONTY) and Array BioPharma Inc.
SAN FRANCISCO, Jan.
Subgroup analyses from a phase III clinical trial comparing a newer chemotherapy agent called eribulin mesylate, with capecitabine, a standard chemotherapy medication in women with previously treated metastatic breast cancer, showed increased benefit among women sharing certain traits.
- One of a pair of round metal cymbals attached to the fingers and struck together for rhythm and percussion in belly dancing.